Topic Intelligence: disease

Last updated: 2026-02-19 20:38:27 ET

Overall Topic Sentiment (Range Avg): Optimistic 13.4

Mentions (24h)

vs prior 24h: -100.0%

Mentions (Range)

8 day range (Feb 12 - Feb 19)

Sentiment (Avg / Median)

13.4 / 0.0

Based on 5 articles in range

Sentiment Mix (Range)

40% 40% 20%

Coverage Z-Score

-1.58

24h mentions vs 90d baseline

Topic Share of Voice (History)

Top Sources (Range)

Mentions by Hour (24h ET)

No hourly mention data available.

Related Co-Topics (Range)

pfe (3) sickle (1) cell (1) competitive (1) landscape (1) comprehensive (1) analysis (1) rheumatoid (1) arthritis (1) drugs (1) markets (1) opportunities (1) emerging (1) inhibitors (1) roche (1) gazyva (1) head (1) holding (1) reframe (1) long (1)

Latest Articles on "disease" (Range)

finance.yahoo.com • 1d ago

Sickle Cell Disease Competitive Landscape Report 2026: Comprehensive Analysis of Over 40 Companies and More Than 50 Drugs

Opportunities in the Sickle Cell Disease market include advancing gene-editing therapies like EDIT-301, expanding VOC-reducing treatments such as incl...

Neutral 0.0

finance.yahoo.com • 1d ago

$37 Bn Rheumatoid Arthritis Drugs Markets, 2026-2036: Opportunities in Emerging JAK Inhibitors, Technological Advancements, and Increasing Organic Strategies Among Market Players

The rheumatoid arthritis market is poised for growth due to the rising adoption of advanced disease-modifying therapies, fostering deeper patient rete...

Strong Bullish 100.0

simplywall.st • 1d ago

Rocheâ€™s Gazyva Data And New R&D Head Reframe Long Term Story

Roche Holding (SWX:ROG) reported positive Phase III MAJESTY trial results for Gazyva in primary membranous nephropathy. The company announced Gazyva a...

Bullish 67.0

The Guardian World News • 1d ago

Excruciating tropical disease can now be transmitted in most of Europe, study finds

‘Shocking’ data shows the climate crisis and invasive mosquitos mean chikungunya could spread in 29 countriesAn excruciatingly painful tropical di...

Strong Bearish -100.0

Bezinga News • 1d ago

HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the "Company"), (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical c...